Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Clementi

Showing results (271-280 of 281) with videos related to

Pageof 29
Sort By:
Frontiers in Immunology|June 14, 2018
Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase InhibitionCristiana Perrotta, Davide Cervia, Ilaria Di Renzo, et al.
International Journal of Environmental Research and Public Health|December 23, 2022
Association between Perceived Health-Related Quality of Life and Depression with Frailty in the FRASNET StudyGiulia B Delli Zotti, Lorena Citterio, Sara Farinone, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2008
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatmentClaudia Colussi, Chiara Mozzetta, Aymone Gurtner, et al.
Expert Opinion on Drug Safety|November 24, 2016
Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switchConcetta Rafaniello, Marco Pozzi, Simone Pisano, et al.
European Journal of Clinical Pharmacology|November 29, 2015
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settingsMarco Pozzi, Dario Cattaneo, Sara Baldelli, et al.
The Journal of Clinical Psychiatry|October 26, 2016
Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic ComparisonMarco Pozzi, Simone Pisano, Silvana Bertella, et al.
Cell Death and Differentiation|July 15, 2020
Defective endoplasmic reticulum-mitochondria contacts and bioenergetics in SEPN1-related myopathyAnne Filipe, Alexander Chernorudskiy, Sandrine Arbogast, et al.
Cell Death & Disease|April 8, 2025
The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recoveryMatteo Giovarelli, Silvia Zecchini, Silvia Rosanna Casati, et al.
Frontiers in Immunology|May 3, 2021
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study GroupFrancesca Ferretti, Rosanna Cannatelli, Maurizio Benucci, et al.
Free Radical Biology & Medicine|September 26, 2024
Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signalingDavide Cervia, Silvia Zecchini, Luca Pincigher, et al.
Pageof 29

Showing results (271-280 of 281) with videos related to

Sort By:
Pageof 29
Frontiers in Immunology|June 14, 2018
Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase InhibitionCristiana Perrotta, Davide Cervia, Ilaria Di Renzo, et al.
International Journal of Environmental Research and Public Health|December 23, 2022
Association between Perceived Health-Related Quality of Life and Depression with Frailty in the FRASNET StudyGiulia B Delli Zotti, Lorena Citterio, Sara Farinone, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2008
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatmentClaudia Colussi, Chiara Mozzetta, Aymone Gurtner, et al.
Expert Opinion on Drug Safety|November 24, 2016
Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switchConcetta Rafaniello, Marco Pozzi, Simone Pisano, et al.
European Journal of Clinical Pharmacology|November 29, 2015
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settingsMarco Pozzi, Dario Cattaneo, Sara Baldelli, et al.
The Journal of Clinical Psychiatry|October 26, 2016
Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic ComparisonMarco Pozzi, Simone Pisano, Silvana Bertella, et al.
Cell Death and Differentiation|July 15, 2020
Defective endoplasmic reticulum-mitochondria contacts and bioenergetics in SEPN1-related myopathyAnne Filipe, Alexander Chernorudskiy, Sandrine Arbogast, et al.
Cell Death & Disease|April 8, 2025
The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recoveryMatteo Giovarelli, Silvia Zecchini, Silvia Rosanna Casati, et al.
Frontiers in Immunology|May 3, 2021
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study GroupFrancesca Ferretti, Rosanna Cannatelli, Maurizio Benucci, et al.
Free Radical Biology & Medicine|September 26, 2024
Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signalingDavide Cervia, Silvia Zecchini, Luca Pincigher, et al.
Pageof 29